United States Pharmaceuticals

NextCure Inc (NXTC)

Track

Track

NextCure Inc. recorded 14 insider trading transactions over the past 90 days. ADAR1 Capital Management, LLC aggressively accumulated shares, totaling over $1.7 million in purchases. Conversely, Simcere Zaiming, Inc. executed a $184,800 sale. These activities occurred alongside a 269.2% stock price increase and a positive earnings report beat of 7.07%.
Ticker: NXTC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for NextCure Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Sofinnova Venture Partners IX, L.P. Large shareholder
Transaction date
Purchase
Price
36.75
Quantity 150,000 +5.9%
Value US$5,512,500
CANAAN X L.P. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 50,000 +2.3%
Value US$750,000
3.3
Xu Stella
Transaction date
Purchase
Price
15.00
Quantity 125,000 +12.8%
Value US$1,875,000
2.5
Khuong Chau Quang
Transaction date
Purchase
Price
15.00
Quantity 350,000 +14.8%
Value US$5,250,000
3.8
SHANNON TIMOTHY M Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 50,000 +2.3%
Value US$750,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 350,000 +14.8%
Value US$5,250,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-10 S Sale
Simcere Zaiming, Inc.
60,788 +49.0%
82.16
US$531,894 		60,788 +49.0% 82.16 US$531,894
2026-08-03 2026-07-31 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
39,546 -48.4%
187.88
US$4,996,685 		39,546 -48.4% 187.88 US$4,996,685
2026-08-03 2026-07-31 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
76,861 +9.7%
458.94
US$926,738 		76,861 +9.7% 458.94 US$926,738
2026-08-03 2026-07-31 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
3,300 +0.5%
4.98
US$16,420 		3,300 +0.5% 4.98 US$16,420
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
77,850 +12.8%
4.96
US$385,793 		77,850 +12.8% 4.96 US$385,793
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
100,000 +19.7%
4.90
US$490,000 		100,000 +19.7% 4.90 US$490,000
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
25,000 +5.2%
4.81
US$120,338 		25,000 +5.2% 4.81 US$120,338
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
20,000 +4.3%
5.00
US$100,000 		20,000 +4.3% 5.00 US$100,000
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
20,000 +4.5%
5.00
US$100,000 		20,000 +4.5% 5.00 US$100,000
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
50,000 +12.7%
4.97
US$248,615 		50,000 +12.7% 4.97 US$248,615
2026-07-29 2026-07-29 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
1,600 +0.4%
5.00
US$8,000 		1,600 +0.4% 5.00 US$8,000
2026-07-29 2026-07-29 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
1,810 +0.5%
5.00
US$9,050 		1,810 +0.5% 5.00 US$9,050
2026-07-29 2026-07-28 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
6,400 +1.7%
4.95
US$31,677 		6,400 +1.7% 4.95 US$31,677
2026-07-29 2026-07-27 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
7,798 +2.1%
5.00
US$38,985 		7,798 +2.1% 5.00 US$38,985
2019-11-19 2019-11-15 B Purchase Sofinnova Venture Partners IX, L.P. Large shareholder
150,000 +5.9%
36.75
US$5,512,500 		150,000 +5.9% 36.75 US$5,512,500
2019-05-15 2019-05-13 B Purchase
3.6
Sofinnova Venture Partners IX, L.P.
Large shareholder
400,000 +18.9%
15.00
US$6,000,000 		400,000 +18.9% 15.00 US$6,000,000
2019-05-13 2019-05-13 B Purchase
CANAAN X L.P.
Large shareholder
50,000 +2.3%
15.00
US$750,000 		50,000 +2.3% 15.00 US$750,000
2019-05-13 2019-05-13 B Purchase
3.3
Xu Stella
125,000 +12.8%
15.00
US$1,875,000 		125,000 +12.8% 15.00 US$1,875,000
2019-05-13 2019-05-13 B Purchase
2.5
Khuong Chau Quang
350,000 +14.8%
15.00
US$5,250,000 		350,000 +14.8% 15.00 US$5,250,000
2019-05-13 2019-05-13 B Purchase
3.8
SHANNON TIMOTHY M
Non-Executive Director
50,000 +2.3%
15.00
US$750,000 		50,000 +2.3% 15.00 US$750,000
2019-05-13 2019-05-13 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
350,000 +14.8%
15.00
US$5,250,000 		350,000 +14.8% 15.00 US$5,250,000
Explore more

More insider trading research around NextCure Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America